MedNet.nl: A recent phase II study shows encouraging results for the neoadjuvant treatment of cutaneous squamous cell carcinoma with the PD-1 inhibitor cemiplimab.
26-10-2023 | Cutaneous Squamous Cell Carcinoma | News
ESMO 2023
26-10-2023 | Cutaneous Squamous Cell Carcinoma | News
MedNet.nl: A recent phase II study shows encouraging results for the neoadjuvant treatment of cutaneous squamous cell carcinoma with the PD-1 inhibitor cemiplimab.